254 related articles for article (PubMed ID: 36183389)
21. Mineral and Bone Disorder and Its Association with Cardiovascular Parameters in Chinese Patients with Chronic Kidney Disease.
Zhou C; Wang F; Wang JW; Zhang LX; Zhao MH
Chin Med J (Engl); 2016 Oct; 129(19):2275-80. PubMed ID: 27647184
[TBL] [Abstract][Full Text] [Related]
22. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)].
Omata M; Fukagawa M; Kakuta T
Clin Calcium; 2015 May; 25(5):645-53. PubMed ID: 25926567
[TBL] [Abstract][Full Text] [Related]
23. Role of crosstalk between endothelial cells and smooth muscle cells in vascular calcification in chronic kidney disease.
Zhang YX; Tang RN; Wang LT; Liu BC
Cell Prolif; 2021 Mar; 54(3):e12980. PubMed ID: 33502070
[TBL] [Abstract][Full Text] [Related]
24. Apelin: A novel inhibitor of vascular calcification in chronic kidney disease.
Han X; Wang LY; Diao ZL; Liu WH
Atherosclerosis; 2016 Jan; 244():1-8. PubMed ID: 26581047
[TBL] [Abstract][Full Text] [Related]
25. Spironolactone dose‑dependently alleviates the calcification of aortic rings cultured in hyperphosphatemic medium with or without hyperglycemia by suppressing phenotypic transition of VSMCs through downregulation of Pit‑1.
Wang P; Quan Z; Luo D; Chen W; Peng D
Mol Med Rep; 2019 May; 19(5):3622-3632. PubMed ID: 30896801
[TBL] [Abstract][Full Text] [Related]
26. Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?
Cozzolino M; Ureña-Torres P; Vervloet MG; Brandenburg V; Bover J; Goldsmith D; Larsson TE; Massy ZA; Mazzaferro S;
Nephrol Dial Transplant; 2014 Oct; 29(10):1815-20. PubMed ID: 24516228
[TBL] [Abstract][Full Text] [Related]
27. FGF23 Actions in CKD-MBD and other Organs During CKD.
Sun T; Yu X
Curr Med Chem; 2023; 30(7):841-856. PubMed ID: 35761503
[TBL] [Abstract][Full Text] [Related]
28. The Key Role of Phosphate on Vascular Calcification.
Cozzolino M; Ciceri P; Galassi A; Mangano M; Carugo S; Capelli I; Cianciolo G
Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30970562
[TBL] [Abstract][Full Text] [Related]
29. Vascular Calcification-New Insights Into Its Mechanism.
Lee SJ; Lee IK; Jeon JH
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294899
[TBL] [Abstract][Full Text] [Related]
30. Secreted Frizzled-Related Protein 5 Ameliorates Vascular Calcification in a Rat Model of Chronic Kidney Disease through the Wnt/β-Catenin Pathway.
Deng D; Han X; Diao Z; Liu W
Kidney Blood Press Res; 2021; 46(6):758-767. PubMed ID: 34469882
[TBL] [Abstract][Full Text] [Related]
31. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
Meng Y; Zhang H; Li Y; Li Q; Zuo L
Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
[TBL] [Abstract][Full Text] [Related]
32. Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario?
Liabeuf S; Okazaki H; Desjardins L; Fliser D; Goldsmith D; Covic A; Wiecek A; Ortiz A; Martinez-Castelao A; Lindholm B; Suleymanlar G; Mallamaci F; Zoccali C; London G; Massy ZA
Nephrol Dial Transplant; 2014 Jul; 29(7):1275-84. PubMed ID: 24009287
[TBL] [Abstract][Full Text] [Related]
33. CKAP4 contributes to the progression of vascular calcification (VC) in chronic kidney disease (CKD) by modulating YAP phosphorylation and MMP2 expression.
Shi Y; Jin X; Yang M; Jia J; Yao H; Yuan W; Wang K; Rong S
Cell Signal; 2022 May; 93():110270. PubMed ID: 35108641
[TBL] [Abstract][Full Text] [Related]
34. Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia.
Yamada S; Tokumoto M; Tatsumoto N; Taniguchi M; Noguchi H; Nakano T; Masutani K; Ooboshi H; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1418-28. PubMed ID: 24808541
[TBL] [Abstract][Full Text] [Related]
35. Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.
Mathew S; Davies M; Lund R; Saab G; Hruska KA
Eur J Clin Invest; 2006 Aug; 36 Suppl 2():43-50. PubMed ID: 16884397
[TBL] [Abstract][Full Text] [Related]
36. Role of hyperphosphatemia-mediated vascular calcification in cardiovascular outcomes and its management: a review.
Latif F; Khalid MM; Khan F; Omar Z; Ali FA
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):410-5. PubMed ID: 23392553
[TBL] [Abstract][Full Text] [Related]
37. Mineral Bone Abnormalities and Vascular Calcifications.
Ray M; Jovanovich A
Adv Chronic Kidney Dis; 2019 Nov; 26(6):409-416. PubMed ID: 31831119
[TBL] [Abstract][Full Text] [Related]
38. Advances in pharmacotherapy for hyperphosphatemia in renal disease.
Spasovski G
Expert Opin Pharmacother; 2015; 16(17):2589-99. PubMed ID: 26374200
[TBL] [Abstract][Full Text] [Related]
39. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches.
Düsing P; Zietzer A; Goody PR; Hosen MR; Kurts C; Nickenig G; Jansen F
J Mol Med (Berl); 2021 Mar; 99(3):335-348. PubMed ID: 33481059
[TBL] [Abstract][Full Text] [Related]
40. The Importance of Phosphate Control in Chronic Kidney Disease.
Tsuchiya K; Akihisa T
Nutrients; 2021 May; 13(5):. PubMed ID: 34069053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
